摘要
分析尼莫通治疗129例急性脑损伤患者的临床疗效,并随机抽取120例未用尼莫通治疗的急性脑损伤患者作对照。结果显示:尼莫通组和对照组在尼莫通治疗前 GCS 计分无显著差异(P>0.05)。治疗后 GCS 计分明显提高,尼莫通组 GCS 13～15分者占75.97%,高于对照组54.17%(P<0.05)。尼莫通对神经系统症状、意识障碍、肢体运动障碍和语言障碍的总有效率分别为93.88%、94.05%、95.2%和87.94%。尼莫通使用过程中无明显不良反应,对急性脑损伤引起的意识与神经功能障碍效果显著。
This paper analyses the clinical effect of Nimotop on patients with acute brain injury,or- der to improve their outcome,we were retrospectively studied 129 cases of acute brain injuey about the GCS score and the clinical manifestation,and using 120 cases of no Nimotop on pa- tients with acute brain injury for control.The results indicated the difference of GCS score is not significant(P>0.05)between Nimotop and control group before treatment.GCS score significantly increased after Nimotop given,and the rate of the cases of GCS 13～15 in Nimo- top group was 75.17%,superior to that of the control group which was 54.17%(P<0. 05).The total effective rate of Nimotop on nervous system symptom,consciousness dis- tubances,motor distubances and language distubances was 93.88%,94.05%,95.2% and 87.94% respectively.No harmful reaction in the course of Nimotop application was found. Nimotop has marked therapeutic effect on acute brain injury.
出处
《江西医学院学报》
1998年第4期79-82,共4页
Acta Academiae Medicinae Jiangxi
